v3.24.3
Condensed Consolidated Statements of Changes in Redeemable Common Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Series A Common Stock
Series B Common Stock
Conversion of Redeemable Common Stock
Conversion of Common Stock Upon Initial Public Offering
Conversion of Common Stock Upon Shareholder Election And Vesting of Certain Equity Awards
Common Stock
Series A Common Stock
Common Stock
Series B Common Stock
Common Stock
Conversion of Redeemable Common Stock
Series A Common Stock
Common Stock
Conversion of Redeemable Common Stock
Series B Common Stock
Common Stock
Conversion of Common Stock Upon Initial Public Offering
Series A Common Stock
Common Stock
Conversion of Common Stock Upon Initial Public Offering
Series B Common Stock
Common Stock
Conversion of Common Stock Upon Shareholder Election And Vesting of Certain Equity Awards
Series A Common Stock
Common Stock
Conversion of Common Stock Upon Shareholder Election And Vesting of Certain Equity Awards
Series B Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Conversion of Redeemable Common Stock
Accumulated Deficit
Accumulated Deficit
Conversion of Redeemable Common Stock
Beginning balance (in shares) at Dec. 31, 2022 64,046,223                                  
Beginning balance at Dec. 31, 2022 $ 1,531,853                                  
Redeemable Common Stock                                    
Accretion of redeemable common stock to redemption value $ 399,685                                  
Reclassification of redeemable common stock to Series B common stock (in shares) (64,046,223)                                  
Reclassification of redeemable common stock to Series B common stock $ (1,931,538)                                  
Ending balance (in shares) at Sep. 30, 2023 0                                  
Ending balance at Sep. 30, 2023 $ 0                                  
Beginning balance (in shares) at Dec. 31, 2022             0 170,855,313                    
Beginning balance at Dec. 31, 2022 (1,036,183)           $ 0 $ 171             $ 1,249,065   $ (2,285,419)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Accretion of redeemable common stock to redemption value (399,685)                           (399,685)      
Issuance of common stock upon exercise of common stock options (in shares)               2,309,707                    
Issuance of common stock upon exercise of common stock options 3,933             $ 3             3,930      
Issuance of common stock upon vesting of restricted stock units (in shares)               6,162,692                    
Issuance of common stock upon vesting of restricted stock units 0             $ 6             (6)      
Issuance of common stock upon exercise of collaboration agreement warrants (in shares)               5,706,904                    
Issuance of common stock upon exercise of collaboration agreement warrants 57             $ 5             52      
Vested warrants related to collaboration agreement 134,225                           134,225      
Stock-based compensation expense 303,534                           303,534      
Vesting of restricted stock common stock (in shares)               26,795                    
Vesting of restricted common stock 75                           75      
Vesting of restricted stock units (in shares)               33,333                    
Vesting of restricted stock units 0                                  
Issuance of common stock in connection with Initial Public Offering (in shares)             11,507,693                      
Issuance of common stock in connection with Initial Public Offering 319,953           $ 12               319,941      
Shares withheld for tax withholding upon vesting of restricted stock units (in shares)               (2,350,702)                    
Tax withholdings on settlement of stock-based awards (70,165)             $ (2)             (70,163)      
Conversion of common stock (in shares)                   64,046,223 21,233,074 (21,233,074)            
Conversion of common stock       $ 1,931,538 $ 0         $ 64 $ 21 $ (21)       $ 136,865   $ 1,794,609
Net loss (281,938)                               (281,938)  
Ending balance (in shares) at Sep. 30, 2023             32,740,767 225,557,191                    
Ending balance at Sep. 30, 2023 $ 905,344           $ 33 $ 226             1,677,833   (772,748)  
Beginning balance (in shares) at Jun. 30, 2023 64,046,223                                  
Beginning balance at Jun. 30, 2023 $ 1,625,825                                  
Redeemable Common Stock                                    
Accretion of redeemable common stock to redemption value $ 305,713                                  
Reclassification of redeemable common stock to Series B common stock (in shares) (64,046,223)                                  
Reclassification of redeemable common stock to Series B common stock $ (1,931,538)                                  
Ending balance (in shares) at Sep. 30, 2023 0                                  
Ending balance at Sep. 30, 2023 $ 0                                  
Beginning balance (in shares) at Jun. 30, 2023             0 173,222,733                    
Beginning balance at Jun. 30, 2023 (1,082,474)           $ 0 $ 173             1,187,606   (2,270,253)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Accretion of redeemable common stock to redemption value (305,713)                           (305,713)      
Issuance of common stock upon exercise of common stock options (in shares)               1,174,225                    
Issuance of common stock upon exercise of common stock options 1,591             $ 1             1,590      
Issuance of common stock upon vesting of restricted stock units (in shares)               6,162,692                    
Issuance of common stock upon vesting of restricted stock units 0             $ 6             (6)      
Issuance of common stock upon exercise of collaboration agreement warrants (in shares)               4,526,162                    
Issuance of common stock upon exercise of collaboration agreement warrants 46             $ 5             41      
Vested warrants related to collaboration agreement 106,455                           106,455      
Stock-based compensation expense 301,192                           301,192      
Vesting of restricted stock common stock (in shares)               8,932                    
Vesting of restricted common stock 25                           25      
Issuance of common stock in connection with Initial Public Offering (in shares)             11,507,693                      
Issuance of common stock in connection with Initial Public Offering 319,953           $ 12               319,941      
Shares withheld for tax withholding upon vesting of restricted stock units (in shares)               (2,350,702)                    
Tax withholdings on settlement of stock-based awards (70,165)             $ (2)             (70,163)      
Conversion of common stock (in shares)                   64,046,223 21,233,074 (21,233,074)            
Conversion of common stock       1,931,538 $ 0         $ 64 $ 21 $ (21)       $ 136,865   $ 1,794,609
Net loss (297,104)                               (297,104)  
Ending balance (in shares) at Sep. 30, 2023             32,740,767 225,557,191                    
Ending balance at Sep. 30, 2023 $ 905,344           $ 33 $ 226             1,677,833   (772,748)  
Beginning balance (in shares) at Dec. 31, 2023 0                                  
Beginning balance at Dec. 31, 2023 $ 0                                  
Ending balance (in shares) at Sep. 30, 2024 0                                  
Ending balance at Sep. 30, 2024 $ 0                                  
Beginning balance (in shares) at Dec. 31, 2023   40,841,834 218,524,009       40,841,834 218,524,009                    
Beginning balance at Dec. 31, 2023 914,777           $ 41 $ 219             1,713,560   (799,043)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of common stock upon exercise of common stock options (in shares)               5,091,283                    
Issuance of common stock upon exercise of common stock options 6,217             $ 5             6,212      
Issuance of common stock upon vesting of restricted stock units (in shares)             805,702 3,325,308                    
Issuance of common stock upon vesting of restricted stock units 0           $ 1 $ 3             (4)      
Issuance of common stock upon exercise of collaboration agreement warrants (in shares)               1,033,147                    
Issuance of common stock upon exercise of collaboration agreement warrants 10             $ 0             10      
Issuance of common stock under the employee stock purchase plan (in shares)             206,156                      
Issuance of common stock under the employee stock purchase plan 4,362           $ 0               4,362      
Vested warrants related to collaboration agreement 24,300                           24,300      
Stock-based compensation expense 103,508                           103,508      
Shares withheld for tax withholding upon vesting of restricted stock units (in shares)             (71,202) (581,784)                    
Tax withholdings on settlement of stock-based awards (19,264)             $ 0             (19,264)      
Conversion of common stock (in shares)                 36,695,775 (36,695,775)                
Conversion of common stock       $ 0         $ 36 $ (36)                
Net loss (19,169)                               (19,169)  
Ending balance (in shares) at Sep. 30, 2024   78,478,265 190,696,188       78,478,265 190,696,188                    
Ending balance at Sep. 30, 2024 $ 1,014,741           $ 78 $ 191             1,832,684   (818,212)  
Beginning balance (in shares) at Jun. 30, 2024 0                                  
Beginning balance at Jun. 30, 2024 $ 0                                  
Ending balance (in shares) at Sep. 30, 2024 0                                  
Ending balance at Sep. 30, 2024 $ 0                                  
Beginning balance (in shares) at Jun. 30, 2024             72,510,738 194,081,029                    
Beginning balance at Jun. 30, 2024 979,500           $ 73 $ 194             1,796,100   (816,867)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of common stock upon exercise of common stock options (in shares)               706,906                    
Issuance of common stock upon exercise of common stock options 1,540             $ 1             1,539      
Issuance of common stock upon vesting of restricted stock units (in shares)             483,175 1,225,134                    
Issuance of common stock upon vesting of restricted stock units 0             $ 1             (1)      
Issuance of common stock upon exercise of collaboration agreement warrants (in shares)               344,384                    
Issuance of common stock upon exercise of collaboration agreement warrants 3             $ 0             3      
Vested warrants related to collaboration agreement 8,100                           8,100      
Stock-based compensation expense 32,438                           32,438      
Shares withheld for tax withholding upon vesting of restricted stock units (in shares)             (28,017) (148,896)                    
Tax withholdings on settlement of stock-based awards (5,495)             $ 0             (5,495)      
Conversion of common stock (in shares)                         5,512,369 (5,512,369)        
Conversion of common stock           $ 0             $ 5 $ (5)        
Net loss (1,345)                               (1,345)  
Ending balance (in shares) at Sep. 30, 2024   78,478,265 190,696,188       78,478,265 190,696,188                    
Ending balance at Sep. 30, 2024 $ 1,014,741           $ 78 $ 191             $ 1,832,684   $ (818,212)